Eagle Rock Investment Company LLC Increases Position in GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Eagle Rock Investment Company LLC lifted its holdings in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC - Free Report) by 71.7% during the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 62,121 shares of the company's stock after purchasing an additional 25,936 shares during the quarter. Eagle Rock Investment Company LLC's holdings in GE HealthCare Technologies were worth $4,857,000 as of its most recent filing with the SEC.

Several other hedge funds and other institutional investors have also made changes to their positions in the business. LGT Financial Advisors LLC increased its holdings in GE HealthCare Technologies by 1,673.3% during the 3rd quarter. LGT Financial Advisors LLC now owns 266 shares of the company's stock worth $25,000 after purchasing an additional 251 shares during the period. Fred Alger Management LLC acquired a new position in shares of GE HealthCare Technologies during the second quarter worth about $26,000. Capital Performance Advisors LLP purchased a new stake in shares of GE HealthCare Technologies during the third quarter worth approximately $26,000. Ashton Thomas Securities LLC acquired a new stake in GE HealthCare Technologies in the third quarter valued at approximately $26,000. Finally, Darwin Wealth Management LLC purchased a new position in GE HealthCare Technologies in the third quarter worth approximately $31,000. Hedge funds and other institutional investors own 82.06% of the company's stock.

Insider Buying and Selling

In other GE HealthCare Technologies news, CEO Roland Rott sold 3,577 shares of the business's stock in a transaction on Wednesday, November 6th. The shares were sold at an average price of $86.48, for a total value of $309,338.96. Following the transaction, the chief executive officer now directly owns 24,298 shares of the company's stock, valued at approximately $2,101,291.04. The trade was a 12.83 % decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Corporate insiders own 0.27% of the company's stock.

GE HealthCare Technologies Stock Performance

GEHC stock traded down $0.26 on Friday, hitting $84.74. The company's stock had a trading volume of 2,855,039 shares, compared to its average volume of 3,233,667. The stock has a market cap of $38.72 billion, a price-to-earnings ratio of 23.28, a price-to-earnings-growth ratio of 2.80 and a beta of 1.11. The firm has a 50 day moving average of $82.00 and a two-hundred day moving average of $84.27. The company has a current ratio of 1.23, a quick ratio of 0.98 and a debt-to-equity ratio of 1.12. GE HealthCare Technologies Inc. has a 1 year low of $71.31 and a 1 year high of $94.55.

GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) last announced its earnings results on Wednesday, October 30th. The company reported $1.14 earnings per share for the quarter, topping the consensus estimate of $1.06 by $0.08. The business had revenue of $4.86 billion during the quarter, compared to the consensus estimate of $4.87 billion. GE HealthCare Technologies had a net margin of 8.56% and a return on equity of 25.19%. The business's quarterly revenue was up .9% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $0.99 earnings per share. Equities analysts predict that GE HealthCare Technologies Inc. will post 4.3 EPS for the current fiscal year.

GE HealthCare Technologies Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, February 14th. Stockholders of record on Tuesday, January 14th will be paid a dividend of $0.035 per share. This represents a $0.14 annualized dividend and a dividend yield of 0.17%. The ex-dividend date is Tuesday, January 14th. This is a boost from GE HealthCare Technologies's previous quarterly dividend of $0.03. GE HealthCare Technologies's dividend payout ratio is 3.30%.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently weighed in on GEHC shares. Stifel Nicolaus raised their price objective on shares of GE HealthCare Technologies from $100.00 to $102.00 and gave the company a "buy" rating in a report on Monday, September 30th. Wells Fargo & Company raised their price target on GE HealthCare Technologies from $95.00 to $96.00 and gave the company an "overweight" rating in a research note on Thursday, October 31st. UBS Group cut GE HealthCare Technologies from a "neutral" rating to a "sell" rating and lowered their price objective for the stock from $84.00 to $74.00 in a research report on Thursday, September 26th. Evercore ISI raised their target price on GE HealthCare Technologies from $98.00 to $102.00 and gave the stock an "outperform" rating in a research report on Tuesday, October 1st. Finally, Jefferies Financial Group upgraded GE HealthCare Technologies from a "hold" rating to a "buy" rating and boosted their target price for the stock from $95.00 to $103.00 in a research note on Wednesday, January 8th. One investment analyst has rated the stock with a sell rating, four have given a hold rating, nine have given a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat, the company presently has a consensus rating of "Moderate Buy" and a consensus target price of $96.00.

About GE HealthCare Technologies

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.